切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2026, Vol. 16 ›› Issue (01) : 45 -51. doi: 10.3877/cma.j.issn.2095-1221.2026.01.006

综述

间充质干细胞改善术后认知功能障碍的作用机制与研究进展
黄立政1, 王玉倩2, 姜金兰2, 韩方雷1,()   
  1. 1130033 长春,吉林大学中日联谊医院麻醉科
    2130033 长春,吉林大学中日联谊医院科学研究中心
  • 收稿日期:2025-11-13 出版日期:2026-02-01
  • 通信作者: 韩方雷

Mechanisms and research progress of mesenchymal stem cells in improving postoperative cognitive dysfunction

Lizheng Huang1, Yuqian Wang2, Jinlan Jiang2, Fanglei Han1,()   

  1. 1Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Chang Chun 130033, China
    2Scientific Research Center, China-Japan Union Hospital of Jilin University, Chang Chun 130033, China
  • Received:2025-11-13 Published:2026-02-01
  • Corresponding author: Fanglei Han
引用本文:

黄立政, 王玉倩, 姜金兰, 韩方雷. 间充质干细胞改善术后认知功能障碍的作用机制与研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(01): 45-51.

Lizheng Huang, Yuqian Wang, Jinlan Jiang, Fanglei Han. Mechanisms and research progress of mesenchymal stem cells in improving postoperative cognitive dysfunction[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2026, 16(01): 45-51.

术后认知功能障碍(POCD)是老年患者手术后常见的中枢神经系统并发症,主要表现为记忆力减退、注意力不集中和执行功能下降等认知功能损害,目前临床缺乏有效的防治手段。间充质干细胞(MSCs)因其具备多谱系分化能力及旁分泌效应,在神经退行性与损伤性疾病干预中受到广泛关注,为POCD防治提供新方向。本综述系统阐述MSCs防治POCD的核心机制,重点归纳其通过免疫调节、神经营养支持、缓解氧化应激及修复血脑屏障等多途径发挥的治疗潜力,分析其来源选择、给药策略及临床前研究证据,并展望通过细胞工程技术优化等方向,推动其成为POCD防治的新型有效疗法。

Postoperative cognitive dysfunction (POCD) is a common central nervous system complication in elderly patients following surgery, primarily characterized by cognitive impairments such as memory decline, inattention, and reduced executive function. Currently, there is a lack of effective clinical strategies for its prevention and treatment. Mesenchymal stem cells (MSCs) have garnered widespread attention in the intervention of neurodegenerative and injury-related neurological diseases due to their multi-lineage differentiation potential and significant paracrine effects. This review systematically elucidates the core mechanisms by which MSCs prevent and treat POCD, with a focus on summarizing their therapeutic potential through multiple pathways including immunomodulation, neurotrophic support, alleviation of oxidative stress, and repair of the blood-brain barrier. It also analyzes the selection of MSCs sources, administration strategies, and preclinical research evidence. Furthermore, the review outlines future directions, such as optimization through cellular engineering techniques, to advance MSCs as a novel and effective therapeutic approach for POCD prevention and treatment.

图1 术后认知功能障碍的病理生理机制(Biorender绘图网站绘制)注:IL-1β为白细胞介素-1β;TNF-α为肿瘤坏死因子-α;IL-6为白细胞介素-6;LTP为长时程增强;ROS为活性氧
表1 MSCs治疗POCD的临床前研究总结
模型 MSCs类型 给药途径 主要效果 参考文献
体外循环的大鼠 AMSCs 尾静脉 通过TLR2/4信号激动剂干预,外泌体组大鼠的游泳距离和停留时间有所改善(P < 0.05)。且在CPB组大鼠中TLR2、TLR4、MyD88和NF-κB的mRNA和蛋白质表达增加(P < 0.05),AMSCs的外泌体补充剂则抑制这一增长,来改善CPB大鼠的认知功能 Yang等[66]
肝左叶切除术的小鼠 MSCs-CM 尾静脉 MSCs-CM治疗可以逆转对照组中脑IL-1β、IL-6、TNF-α、丙二醛水平升高和BDNF表达减少等变化(P < 0.05),进而改善小鼠认知功能 Jiang等[48]
AD大鼠 BUMSC-CM 腹腔注射 BUMSC-CM具有神经保护潜力,通过上调BDNF和NGF,同时下调IL-1β和TNF-α,使AD大鼠接受治疗后的海马区神经元数量增加,进而降低神经退行性疾病的发病风险 Wihadmadyatami等[67]
AD小鼠 BMSC 尾静脉 MSCs可以提高内皮型一氧化氮合酶(eNOS)水平,且eNOS及炎症标志物酶联免疫吸附测定(ELISA)结果显示,治疗组与未治疗组之间差异有统计学意义(P < 0.01),证实MSCs减轻血管性痴呆的积极作用 Lee等[68]
AD小鼠 iPSC-MSC-sEVs 小脑延髓池注射 小鼠大脑皮层及海马区神经元数量较假手术组明显减少,而iPSC-MSC-sEVs可通过抑制链脲佐菌素诱导的散发性小鼠模型(sAD)中NLRP3/GSDMD相关的神经炎症,减少淀粉样蛋白沉积与神经元细胞凋亡(P < 0.05)从而减轻认知损伤 Lin等[69]
肝损伤的大鼠 AdMSC 静脉注射 MSC-EVs治疗大鼠通过小胶质细胞激活以及提升TNF-α和IL-1β水平,增强了物体位置记忆,在径向迷宫中提升了工作记忆和学习指数,与对照组差异有统计学意义(P < 0.05)。同时也可以使轻度肝损伤大鼠的NR2B膜表达正常化,改善工作记忆障碍 Mincheva等[70]
SAE小鼠 MSCs-exo 尾静脉 MSCs-exo可以提高脂多糖诱导的细胞中的谷胱甘肽水平,同时其介导的miR-140-3p递送可通过调控HMGB1及S-乳酰谷胱甘肽代谢途径(P < 0.05),改善SAE小鼠的认知功能障碍 Ma等[71]
表2 临床试验中MSCs对神经系统疾病疗效的总结
NCT号码 日期 疾病 机制 干预/治疗 来源 主要指标 地点
NCT01309061 2008.03 进行性半侧萎缩症 利用AdMSC的"归巢"特性,通过肌肉注射进行细胞治疗 自体AdMSC移植 脂肪 脂肪层的体积变化、脂肪吸收率 韩国,首尔
NCT02497443 2011.04 癫痫 注射自体MSCs,利用其免疫调节和神经保护等作用来干预和改善难治性癫痫的疾病进程 自体MSCs注射 骨髓 临床观察和脑电图测量 白俄罗斯
NCT02987413 2015.04 肌萎缩侧索硬化症 鞘内注射递增剂量的自体MSCs,利用MSCs的治疗可塑性,来治疗肌萎缩侧索硬化症 自体MSCs鞘内输注 自体 ALS功能评定量表 巴西,圣保罗
NCT02611167 2017.11 特发性帕金森病 静脉输注不同剂量的同种异体BMSC,利用其神经保护、抗炎和免疫调节功能评估其对延缓特发性帕金森病患者疾病进展的安全性和初步有效性 不同剂量的同种异体BMSC静脉输注 骨髓 帕金森病评定量表总分评估 美国,休斯敦
NCT04388982 2020.07 阿尔茨海默病 利用同种异体脂肪间充质干细胞源外泌体,通过其内含的生物活性物质,调节阿尔茨海默病的病理过程 不同剂量的脂肪间充质干细胞源外泌体用于鼻滴漏 脂肪 阿尔茨海默病评估量表、磁共振成像神经影像学评估 中国,上海
NCT05284604 2023.01 年龄相关的衰弱 补充因衰老而耗竭的干细胞,利用MSCs的归巢和旁分泌功能来修复组织损伤和调节炎症,从而改善与年龄相关的虚弱状态 自体MSCs静脉输注 骨髓 改良体能测试,6 min步行测试 美国,休斯敦
NCT07084012 2025.08 急性缺血性中风 利用hUC-MSCs的免疫调节和组织修复功能,治疗急性缺血性中风的继发性损伤,并促进神经功能恢复 不同剂量的hUC-MSCs输注 脐带 Rankin量表评分、美国国立卫生研究院卒中量表评分 中国,北京
1
Shen Y, Li X, Yao J. Develop a clinical prediction model for postoperative cognitive dysfunction after major noncardiac surgery in elderly patients: a protocol for a prospective observational study[J]. Gerontology, 2022, 68(5):538-545.
2
Liang Y, Xin X, Wang H, et al. A novel predictive strategy for the incidence of postoperative neurocognitive dysfunction in elderly patients with mild cognitive impairment[J]. Front Aging Neurosci, 2022, 14:985406.
3
任世广, 王丹丹, 胡睿, 等. 老年胃肠肿瘤患者术后认知功能障碍危险因素的研究进展[J]. 中国医学创新, 2025, 22(29):179-184.
4
ávila-Gómez P, Shingai Y, Dash S, et al. Molecular and functional alterations in the cerebral microvasculature in an optimized mouse model of sepsis-associated cognitive dysfunction[J]. eNeuro 2024, 11(9).
5
He K, Zhang J, Zhang W, et al. Hippocampus-based mitochondrial respiratory function decline is responsible for perioperative neurocognitive disorders[J]. Front Aging Neurosci, 2022, 14:772066.
6
van Loo G, Bertrand MJM. Death by TNF: a road to inflammation[J]. Nat Rev Immunol, 2023, 23(5):289-303.
7
Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress[J]. J Neuroinflammation, 2021, 18(1):258.
8
Dong J, Tong W, Liu M, et al. Endosomal traffic disorders: a driving force behind neurodegenerative diseases[J]. Transl Neurodegener, 2024, 13(1):66.
9
Lu T, Ma L, Xu Q, et al. Blood Th17 cells and IL-17A as candidate biomarkers estimating the progression of cognitive impairment in stroke patients[J]. J Clin Lab Anal, 2022, 36(8):e24581.
10
Martins de Carvalho L, Chen WY, and Lasek AW. Epigenetic mechanisms underlying stress-induced depression[J]. Int Rev Neurobiol, 2021, 156:87-126.
11
Garro-Martínez E, Fullana MN, Florensa-Zanuy E, et al. mTOR knockdown in the infralimbic cortex evokes a depressive-like state in mouse[J]. Int J Mol Sci, 2021, 22(16):8671.
12
Latina V, De Introna M, Caligiuri C, et al. Immunotherapy with cleavage-specific 12A12mAb reduces the tau cleavage in visual cortex and improves visuo-spatial recognition memory in Tg2576 AD mouse model[J]. Pharmaceutics, 2023, 15(2):509.
13
Ding Z, Liu Q, and Zhang J. SFRS8 regulates memory by modulating RNA splicing of synaptic genes[J]. Mol Neurobiol, 2025, 62(10): 12523-12538.
14
Chen Q, Zheng A, Xu X, et al. Nrf3-mediated mitochondrial superoxide promotes cardiomyocyte apoptosis and impairs cardiac functions by suppressing Pitx2[J]. Circulation, 2025, 151(14):1024-1046.
15
Han J, Kim YH, Han S. Increased oxidative phosphorylation through pyruvate dehydrogenase kinase 2 deficiency ameliorates cartilage degradation in mice with surgically induced osteoarthritis[J]. Exp Mol Med, 2025, 57(2):390-401.
16
Wu AG, Yong YY, Pan YR, et al. Targeting Nrf2-mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals[J]. Oxid Med Cell Longev, 2022, 2022:1015791.
17
Afzal M, Sidra T, and Li Y. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease[J]. Front Aging Neurosci, 2021, 13:617588.
18
Wei C, Jiang W, Wang R, et al. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown[J]. Nature, 2024, 629(8013): 893-900.
19
Yousef H, Czupalla CJ, Lee D, et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1[J]. Nat Med, 2019, 25(6):988-1000.
20
Tyrrell DJ, Blin MG, Song J, et al. Aging impairs mitochondrial function and mitophagy and elevates interleukin 6 within the cerebral vasculature[J]. J Am Heart Assoc, 2020, 9(23):e017820.
21
Yuki K, Hou L, Shibamura-Fujiogi M, et al. Mechanistic consideration of the effect of perioperative volatile anesthetics on phagocytes[J]. Clin Immunol, 2021, 222:108635.
22
Goel F, Kumar D, Sharma A. Impact of corticoid receptors on Alzheimer's disease: a neuroendocrine perspective[J]. Inflammopharmacology, 2025, 33(5):2641-2656.
23
Samant RR, Standaert DG, Harms AS. The emerging role of disease-associated microglia in Parkinson's disease[J]. Front Cell Neurosci, 2024, 18:1476461.
24
Wang L, Zhao J, Zhu B, et al. Microglia polarization in heat-induced early neural injury[J]. Arch Med Sci, 2024, 20(4):1307-1313.
25
游丽娟, 朱紫文, 徐桂灵, 等. 胎盘间充质干细胞的免疫调节作用及机制[J]. 现代免疫学, 2025, 45(03):344-349.
26
Li Y, Wang F, Guo R, et al. Exosomal sphingosine 1-phosphate secreted by mesenchymal stem cells regulated Treg/Th17 balance in aplastic anemia[J]. IUBMB Life, 2019, 71(9):1284-1292.
27
Laing AG, Fanelli G, Ramirez-Valdez A, et al. Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress[J]. PLoS One, 2019, 14(3):e0213170.
28
Hu H, Li H, Li R, et al. Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17/Treg balance[J]. J Transl Med, 2024, 22(1):663.
29
李明芬. 骨髓间充质干细胞对CD8+ T淋巴细胞的免疫调节功能及其机制研究[D]. 广西医科大学, 2014.
30
Sun LH, Tian D, Yang ZC, et al. Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4[J]. Sci Rep, 2020, 10(1):8271.
31
Gu J, Wu J, Wang C, et al. BMSCs-derived exosomes inhibit macrophage/microglia pyroptosis by increasing autophagy through the miR-21a-5p/PELI1 axis in spinal cord injury[J]. Aging (Albany NY), 2024, 16(6):5184-5206.
32
Qiao L, Hu S, Liu S, et al. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential[J]. J Clin Invest, 2019, 129(6):2237-2250.
33
Li YX, Liu T, Liang YW, et al. Integrative analysis of long non-coding RNA and messenger RNA expression in toll-like receptor 4-primed mesenchymal stem cells of ankylosing spondylitis[J]. Ann Transl Med, 2021, 9(20):1563.
34
Sun XH, Wang X, Zhang Y, et al. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway[J]. Thromb Res, 2019, 177:23-32.
35
Jiang L, Jones S, and Jia X. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities[J]. Int J Mol Sci, 2017, 18(1):94.
36
Abdel Halim NY, Mohamed GH, Elhusseiny A, et al. IGF 1, BDNF, and NGF mediate the neuro-modulatory role of stem cells in acrylamide-induced hippocampal toxic changes in rats[J]. Folia Morphol (Warsz), 2024, 84(2):328-341.
37
Huang L, Sun X, Wang L, et al. Enhanced effect of combining bone marrow mesenchymal stem cells (BMMSCs) and pulsed electromagnetic fields (PEMF) to promote recovery after spinal cord injury in mice[J]. MedComm (2020), 2022, 3(3):e160.
38
Lech W, Kot M, Welniak-Kaminska M, et al. Dynamic changes in BDNF, VEGF, and GDNF after transplanting human protein-based scaffolds with Wharton's Jelly MSCs in a rat brain injury model[J]. Sci Rep, 2025, 15(1):22625.
39
Hempstead BL. Deciphering proneurotrophin actions[J]. Handb Exp Pharmacol, 2014, 220:17-32.
40
Hei Y, Chen R, Mao X, et al. Neuregulin1 attenuates cognitive deficits and hippocampal CA1 neuronal apoptosis partly via ErbB4 receptor in a rat model of chronic cerebral hypoperfusion[J]. Behav Brain Res, 2019, 365:141-149.
41
Wu L, Cao J, Li N, et al. Novel neuroprotective tetramethylpyrazine analog T-006 promotes neurogenesis and neurological restoration in a rat model of stroke[J]. Neuroreport, 2019, 30(9):658-663.
42
Tan CH, Low KA, Chiarelli AM, et al. Optical measures of cerebral arterial stiffness are associated with white matter signal abnormalities and cognitive performance in normal aging[J]. Neurobiol Aging, 2019, 84:200-207.
43
Ohsawa I, Nishimaki K, Murakami Y, et al. Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity[J]. J Neurosci, 2008, 28(24):6239-6249.
44
Safar MM, Arab HH, Rizk SM, et al. Bone marrow-derived endothelial progenitor cells protect against scopolamine-induced alzheimer-like pathological aberrations[J]. Mol Neurobiol, 2016, 53(3):1403-1418.
45
Kanamaru T, Kamimura N, Yokota T, et al. Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease[J]. Brain Res, 2015, 1605:49-58.
46
Kunst C, Schmid S, Michalski M, et al. The influence of gut microbiota on oxidative stress and the immune system[J]. Biomedicines, 2023, 11(5):1388.
47
Solesio ME, Prime TA, Logan A, et al. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease[J]. Biochim Biophys Acta, 2013, 1832(1):174-182.
48
Jiang Y, Gao H, Yuan H, et al. Amelioration of postoperative cognitive dysfunction in mice by mesenchymal stem cell-conditioned medium treatments is associated with reduced inflammation, oxidative stress and increased BDNF expression in brain tissues[J]. Neurosci Lett, 2019, 709:134372.
49
Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based therapy for human diseases[J]. Signal Transduct Target Ther, 2022, 7(1):272.
50
Deng S, Liu H, Qiu K, et al. Role of the golgi apparatus in the blood-brain barrier: golgi protection may be a targeted therapy for neurological diseases[J]. Mol Neurobiol, 2018, 55(6):4788-4801.
51
Zuo S, Ge H, Li Q, et al. Artesunate protected blood-brain barrier via sphingosine 1 phosphate receptor 1/phosphatidylinositol 3 kinase pathway after subarachnoid hemorrhage in rats[J]. Mol Neurobiol, 2017, 54(2):1213-1228.
52
Ong CW, Pabisiak PJ, Brilha S, et al. Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis[J]. J Neuroinflammation, 2017, 14(1):31.
53
Mechtouff L, Bochaton T, Paccalet A, et al. Matrix metalloproteinase-9 and monocyte chemoattractant protein-1 are associated with collateral status in acute ischemic stroke with large vessel occlusion[J]. Stroke, 2020, 51(7):2232-2235.
54
Barlow S, Brooke G, Chatterjee K, et al. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells[J]. Stem Cells Dev, 2008, 17(6):1095-1107.
55
Al-Sammarraie SHA, Ayaz-Güner Ş, Acar MB, et al. Mesenchymal stem cells from adipose tissue prone to lose their stemness associated markers in obesity related stress conditions[J]. Sci Rep, 2024, 14(1):19702.
56
Asch A, Kalbermatten DF, Madduri S. Clinical safety and efficacy of allogeneic adipose stem cells: a systematic review of the clinical trials[J]. Int J Mol Sci, 2025, 26(13):6376.
57
李嘉鹏, 祖蕾娜·阿布拉, 贾谦谦, 等. 细胞来源外泌体应用于口腔组织再生的优势与潜力[J]. 中国组织工程研究, 2025:1-12.
58
Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect[J]. Stem Cells Dev, 2009, 18(5):683-692.
59
Su Y, Sun B, Gao X, et al. Intranasal delivery of targeted nanoparticles loaded with miR-132 to brain for the treatment of neurodegenerative diseases[J]. Front Pharmacol, 2020, 11:1165.
60
韩立, 惠利健, 潘国宇. 细胞的命运:间充质干细胞的药代动力学[J]. 中国细胞生物学学报, 2018, 40(6):857-866.
61
Huang S, Xu L, Sun Y, et al. The fate of systemically administrated allogeneic mesenchymal stem cells in mouse femoral fracture healing[J]. Stem Cell Res Ther, 2015, 6:206.
62
Stavrou M, Georgiou E, Kleopa KA. Lumbar intrathecal injection in adult and neonatal mice[J]. Curr Protoc, 2024, 4(6):e1091.
63
Shahir M, Mahmoud Hashemi S, Asadirad A, et al. Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells[J]. J Cell Physiol, 2020, 235(10):7043-7055.
64
Lang HL, Zhao YZ, Xiao RJ, et al. Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes[J]. Neural Regen Res, 2023, 18(3):609-617.
65
Zhang J, Huang X, Wang H, et al. The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy[J]. Stem Cell Res Ther, 2015, 6:234.
66
Yang C, Sun S, Zhang Q, et al. Exosomes of antler mesenchymal stem cells improve postoperative cognitive dysfunction in cardiopulmonary bypass rats through inhibiting the TLR2/TLR4 signaling pathway[J]. Stem Cells Int, 2020, 2020:2134565.
67
Wihadmadyatami H, Zulfikar MA, Herawati H, et al. Neuroprotection effect of bovine umbilical mesenchymal stem cell-conditioned medium on the rat model of Alzheimer's disease mediated by upregulation of BDNF and NGF and downregulation of TNF-α and IL-1β[J]. Open Vet J, 2025, 15(1):151-161.
68
Lee WJ, Cho KJ, and Kim GW. Mitigation of atherosclerotic vascular damage and cognitive improvement through mesenchymal stem cells in an Alzheimer's disease mouse model[J]. Int J Mol Sci, 2024, 25(23):13210.
69
Lin L, Huang L, Huang S, et al. MSC-Derived extracellular vesicles alleviate NLRP3/GSDMD-Mediated neuroinflammation in mouse model of sporadic Alzheimer's disease[J]. Mol Neurobiol, 2024, 61(8):5494-5509.
70
Mincheva G, Moreno-Manzano V, Felipo V, et al. Extracellular vesicles from mesenchymal stem cells improve neuroinflammation and neurotransmission in hippocampus and cognitive impairment in rats with mild liver damage and minimal hepatic encephalopathy[J]. Stem Cell Res Ther, 2024, 15(1):472.
71
Ma Y, She X, Liu Y, et al. MSC-derived exosomal miR-140-3p improves cognitive dysfunction in sepsis-associated encephalopathy by HMGB1 and S-lactoylglutathione metabolism[J]. Commun Biol, 2024, 7(1):562.
72
Lee WS, Kim HJ, Kim KI, et al. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: A phase IIb, randomized, placebo-controlled clinical trial[J]. Stem Cells Transl Med, 2019, 8(6):504-511.
73
Zhu Y, Huang C, Zheng L, et al. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase Ⅰ/Ⅱ randomized, double-blind, placebo-controlled study[J]. Stem Cell Res Ther, 2024, 15(1):122.
74
Renesme L, Cobey KD, Lalu MM, et al. Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics[J]. Cytotherapy, 2025, 27(2):146-168.
[1] 中华医学会超声医学分会, 中国研究型医院肿瘤介入治疗委员会, 中国妇幼保健协会乳腺保健专业委员会, 中华医学会肿瘤学分会乳腺癌专业委员会, 中国抗癌协会乳腺癌专业委员会, 中国人体健康科技促进会乳腺专业委员会. 无手术适应证乳腺癌消融治疗专家共识(2025版)[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(01): 1-8.
[2] 董晓培, 袁洋, 李健斌, 宋华, 李凡, 郝艺, 边莉, 王涛, 江泽飞, 张少华. 激素受体阳性、HER-2阴性乳腺癌首发单纯骨转移患者不同一线治疗方式的预后分析[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(01): 25-33.
[3] 栗家兴, 程紫轩, 吕欣悦, 王江芬, 张晶晶, 张亚芬. 肿瘤浸润淋巴细胞在乳腺癌免疫治疗中的作用及其预后预测价值[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(01): 49-54.
[4] 焦瑞, 徐刚, 练慧斌, 殷志敏, 韩辉, 周杰. 骨盆骨折大出血患者动脉栓塞术后臀肌及皮肤坏死治疗方法的探讨[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(01): 7-11.
[5] 刘恒, 何亦龙, 袁蕊, 刘燕燕, 卢帅, 公茂琪, 查晔军, 蒋协远. 免疫与基质调节细胞治疗创伤性异位骨化的实验研究[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(01): 47-53.
[6] 何林霞, 相阳, 刘心如, 郑兴锋. 巨噬细胞代谢重编程在脓毒症急性肺损伤中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(01): 69-74.
[7] 王祝愉, 权晶晶. 人工智能辅助参与牙体牙髓基础与临床研究[J/OL]. 中华口腔医学研究杂志(电子版), 2026, 20(01): 25-33.
[8] 张宇凡, 麦穗. 冲洗剂联合使用在根管治疗中的问题与策略[J/OL]. 中华口腔医学研究杂志(电子版), 2026, 20(01): 74-82.
[9] 伍通美, 杨春燕. 胃癌异时性肝转移外科与转化治疗研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 78-82.
[10] 王龙, 张海翘, 黄勇, 李佳璇, 翟育豪, 尹杰, 张军. 胃韧带样纤维瘤两例报告并文献复习[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 96-98.
[11] 丁小博, 陈洁, 王艳波. 人工智能在泌尿系结石诊治中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 15-21.
[12] 李建雄, 杨诚, 贺慷, 薛康颐, 郭文彬, 陈明坤, 刘存东. 精索静脉曲张伴血栓形成两例报告[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 114-116.
[13] 许鹏, 邓一鸣, 张兴超, 莫益鑫, 郑炯文, 陈春晓, 郭凯, 徐啊白. 广东省医学会泌尿外科疑难病例多学科会诊(第24期)——膀胱憩室癌[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 117-122.
[14] 杨宇尘, 陈拥军. 三维可视化技术在肝癌转化治疗辅助决策中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 10-15.
[15] 慈娟娟, 吴俊成, 朱琴琴. 肝硬化合并食管胃静脉曲张破裂出血患者内镜治疗后再出血风险列线图的构建与验证[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 47-52.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?